PATENT CLAIM ANALYSIS

Application Number: 15772579
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-03
Patent Classification: ["514", "064000"]

Abstract:
The present disclosure relates to, inter alia, a method of treating cancer in a human patient in need thereof, comprising administering a therapeutically effective amount of a substrate of AKR1B1, AKR1B10, or both to said patient, wherein said patient has, or is suspected to have, cancer cells with elevated levels of AKR1B1, AKR1B10, or both, wherein said substrate is not 2-deoxy-D-glucose.

Claim (Index 17):
The method of  claim 3 , wherein the patient is being treated with one or more other anti-cancer therapy or therapeutic agent.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.78049
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14236879', '15127973', '14314342', '15112090', '12280541']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.713048092159798
- 35 USC 102 Novelty (BERT): 0.5059708891887441
- Combined Prediction Score: 0.6923403718626926
- Mean Citation Score: 186.33167
- Max Citation Score: 193.44888
- Similarity Product: 122.91164106064797

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test